Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
06/2005
06/09/2005CA2547459A1 Modulators of nik-siva complex formation for treating immune disorders
06/09/2005CA2547020A1 1h-imidazo[4,5-c]pyridine-4-amine derivatives as immune response modifier
06/09/2005CA2546619A1 Il-23 and its receptor; related reagents and methods
06/09/2005CA2536188A1 Electrical devices and anti-scarring agents
06/08/2005EP1538207A1 Human antihuman mcp-1 antibody and antibody fragment thereof
06/08/2005EP1538198A2 Lactic acid bacteria and their cellular components inducing immunoregulatory function, and method of obtaining the same
06/08/2005EP1537878A1 Immunopotentiating compositions
06/08/2005EP1537877A2 Immunostimulatory polynucleotide/immunomodulatory molecule conjugates
06/08/2005EP1537870A2 Methods and compositions for treating cancer
06/08/2005EP1537138A2 Receptors and membrane-associated proteins
06/08/2005EP1537106A1 Dihydropyrazolopyridine compounds
06/08/2005EP1537096A2 Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics
06/08/2005EP1537087A1 Novel aminoindazole derivatives as medicines and pharmaceutical compositions containing same
06/08/2005EP1537086A2 Novel phenanthridines
06/08/2005EP1537079A2 PHENYL-INDOLE COMPOUNDS FOR MODULATING IgE AND INHIBITING CELLULAR PROLIFERATION
06/08/2005EP1537075A2 Diarylurea derivatives and their use as chloride channel blockers
06/08/2005EP1537069A2 ANALOGUES OF LIPID MEDIATORS DERIVED FROM OMEGA-3 PUFAs AND METHODS OF USE
06/08/2005EP1536850A1 Medical device having hydration inhibitor
06/08/2005EP1536839A2 Method for treating diseases with omega interferon
06/08/2005EP1536834A2 Design of chemokine analogs for the treatment of human diseases
06/08/2005EP1536829A2 Methods for preparing compositions comprising heat shock proteins or alpha-2-macroglobulin useful for the treatment of cancer and infectious disease
06/08/2005EP1536793A1 Pharmaceutical compositions comprising fk506 derivatives and the ir use for the treatment of allergic diseases
06/08/2005EP1536778A2 Proteins binding to cross-beta structure comprising amyloid and methods for detection and modulation of the cross-beta structure, its formation and its associated toxicity
06/08/2005EP1465854A4 Chalcone derivatives and their use to treat diseases
06/08/2005EP1373269B1 Jun kinase inhibitors
06/08/2005EP1309575B1 Biphenyl derivatives and their use as ppar-gamma receptor activators
06/08/2005EP1265595B1 Stabilized ascorbic acid solutions
06/08/2005EP1252133B1 Pharmaceutical compounds
06/08/2005EP1223971B1 Compositions for preventing and treating transplant rejection
06/08/2005EP1206488B1 Method for isolating and purifying grass pollen allergens
06/08/2005EP1176146B1 Carbamoyl tetrahydropyridine derivatives
06/08/2005EP1015459B1 Tetrazole-containing rapamycin analogs with shortened half-lives
06/08/2005EP0849256B1 Amide compounds and use of the same
06/08/2005CN1625603A Genetic polymorphisms in the preprotachykinin gene
06/08/2005CN1625565A Antibodies to non-functional P2X7 receptor, diagnosis and treatment of cancers and other conditions
06/08/2005CN1625557A Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments
06/08/2005CN1625554A Amides of aminoalkyl substituted azetidines, pyrrolidines, piperidines and azepanes
06/08/2005CN1625400A 2, 4-pyrimidinediamine compounds and their uses
06/08/2005CN1624128A Death domain containing receptor 5 antibodies
06/08/2005CN1624115A Cell surface molecule mediating cell adhesion and signal transmission
06/08/2005CN1623985A Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
06/08/2005CN1623556A Anticance auxiliary medicine using proto ginseng triol as effective component and its application
06/08/2005CN1623554A Anticancer auxiliary medicine using C-K as effective component and its application
06/08/2005CN1205223C Insect poison allergens with reduced LgE reactivity and method for producing the same
06/08/2005CN1205222C Method for isolating and purifying grass pollen allergens
06/08/2005CN1205220C Novel cyclosporins
06/08/2005CN1205182C Suplates tosilate crystals
06/08/2005CN1204902C Application of clover extract, used as animal functional food for developing animal immunofunctiona nd anti-retrograde
06/08/2005CN1204897C Licorice polysaccharide powder-injection
06/08/2005CN1204892C Formulations for reducing or eliminating toxicity of environmental hormones containing ursodeoxycholic acid
06/07/2005US6903232 Via crystallization of mixture of para-/meta- regioisomers; for production of terfenadine carboxylate
06/07/2005US6903215 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
06/07/2005US6903204 Polynucleotides encoding methionyl tRNA synthetase from Staphylococcus aureus, related products and methods
06/07/2005US6903187 Structural modification of clostridal neurotoxins including addition or deletion of a leucine-based motif to treat biological disorders include treating autonomic disorders, neuromuscular disorders and pain
06/07/2005US6903137 Agonists specific for the peripheral cannabinoid receptor
06/07/2005US6903134 Formulation comprising benzofuranone derivatives for protection against oxidative stress
06/07/2005US6903132 Non-peptide GnRH agents, pharmaceutical compositions and methods for their use
06/07/2005US6903131 Administering to a patient an antiangiogenesis or anticancer agent (N,N-disubstituted-3,4-diamino-2,4-dione-pyrroline derivatives for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer
06/07/2005US6903128 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
06/07/2005US6903115 Bipiperidine compounds
06/07/2005US6903099 Heterocyclic amides used as preferential inhibitors of cyclic guanosine 3',5'-monophosphate specific phosphodiesterase, for prophylaxis of cardiovascular disorders and erectile dysfunction
06/07/2005US6903098 Use of phthalazine derivatives
06/07/2005US6903088 Compounds which inhibit leukocyte adhesion mediated by VLA-4
06/07/2005US6903086 Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as IP antagonists
06/07/2005US6903085 Substituted piperidine compounds useful as modulators of chemokine receptor activity
06/07/2005US6902885 For detecting viral and cellular polypeptide interactions
06/07/2005US6902734 Also an IL-12 anti-idiotype antibody to the antibody
06/07/2005US6902728 For treating or preventing rejection of transplanted organs, tissues or cells; particularly, use of Met-RANTES together with cyclosporin A to produce pharmaceutical composition for treatment of renal allograft transplant rejection
06/07/2005CA2299036C 4-phenyl-4-heteroarylpiperidine derivatives
06/07/2005CA2281090C Sulfonamide compounds and salts for treatment of endothelin-mediated disorders
06/07/2005CA2209598C Aryl and heteroaryl purine compounds
06/07/2005CA2068790C Antiviral compounds
06/02/2005WO2005048957A2 Novel insertion sites in pox vectors
06/02/2005US20050119320 5-phenylthiazole derivatives and use as pi3 kinase inhibitors
06/02/2005US20050119305 N-hydroxy-6-[(4-phenylbenzoyl)amino]hexanamide; hydroxamic acid derivative and equivalent thereof; antiinflammatory, anticarcinogenic, antiarthritic, antidiabetic agents; sepsis, leukemia, osteoporosis, skin disorders, cachexia, autoimmune diseases, hepatitis, endometriosis; hypergammaglobulinemia
06/02/2005US20050119294 Preparation of 1H-imidazo [4,5-c] quinolin-4-amines via novel 1H-imidazo [4,5-c] quinolin-4-cyano and 1H-imidazo [4,5-c] quinolin-4-carboxamide intermediates
06/02/2005US20050119291 Pyrimidine compounds
06/02/2005US20050119274 3-[5-chloro-6-methyl-2-(4-methyl-piperazin-1-yl)-pyrimidin-4-yl]-4-( 1H-indol-3-yl)-pyrrole-2,5-dione; T lymphocytes, Protein Kinase C (PKC) and glycogen synthase kinase 3 beta (GSK3B) mediated diseases;
06/02/2005US20050119271 Pyrimidine A2B selective antagonist compounds, their synthesis and use
06/02/2005US20050119267 Diazabicyclo alkane derivatives with nk1 antagonistic activity
06/02/2005US20050119255 Phenylpyrimidine amines as ige inhibitors
06/02/2005US20050119250 Amino-derivatives as novel inhibitors of histone deacetylase
06/02/2005US20050119213 Vascular therapeutics
06/02/2005US20050119204 Osteopontin-related compositions and methods
06/02/2005US20050119164 Immunomodulatory polymeric antigens for treating inflammatory pathogies
06/02/2005US20050118638 Using thyrotrophin (TSH) receptor as diagnostic tool in detection of autoimmune diseases; competive binding assay
06/02/2005US20050118573 Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses
06/02/2005US20050118219 1,3,6-trihydroxy-7-methoxy-2,8-di (3-methyl-2-butenyl) xanthone; rosacea and/or telangiectasia, skin aging
06/02/2005US20050118200 Two or more inactivated or attenuated Mycoplasma bovis biotypes, inactivated Mycoplasma alkalescens, an adjuvant and excipient; vaccinating cows; no undesirable side effects and protect against M. bovis related disease, such as contagious mastitis, respiratory pneumonia
06/02/2005US20050118196 Novel therapeutic processes for establishing or enhancing an immunized state, and compositions useful therefor
06/02/2005US20050118192 Viral preparations, vectors, immunogens, and vaccines
06/02/2005US20050118184 Compositions and methods for enhancing the immunogenicity of antigens
06/02/2005US20050118176 Inhibiting binding of interleukin-4 (IL-4) to an IL-4 Receptor; suppressing an IL-4-dependent immune or inflammatory response in a mammal
06/02/2005US20050118173 Compositions and methods to accelerate hematologic recovery
06/02/2005US20050118172 Humanized antibody CAMPATH-1H administered with steroid (hydrocortisone)
06/02/2005US20050118168 Administering a compound which binds to a C-type lectin on the surface of a dendritic cell, with the proviso that the C-type lectin is not the DEC-205 receptor
06/02/2005US20050118161 Hevein-binding monoclonal antibodies
06/02/2005US20050118160 Inhibits delayed vascular rejection; makes organs less vulnerable to rejection after transplantation
06/02/2005CA2554635A1 Compounds, compositions containing such compounds and methods of treatment of autoimmune diseases using such compounds
06/02/2005CA2546195A1 The use of anti biotics as vaccine adjuvants
1 ... 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 ... 1172